Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2021

Nov 15, 2021

33899_dirs_2021-11-15_2f6a98f6-c150-42db-8bb5-738973674619.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2021-11-11

Reporting Person: BYRNES KEVIN G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-11 Common Stock M 2917 $26.52 Acquired 11071 Direct
2021-11-11 Common Stock M 5000 $31.55 Acquired 16071 Direct
2021-11-11 Common Stock M 5000 $27.68 Acquired 21071 Direct
2021-11-11 Common Stock F 6149 $228.45 Disposed 14922 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-11 Stock Options $26.52 M 2917 Disposed 2024-02-05 Common Stock (2917) Direct
2021-11-11 Stock Options $31.55 M 5000 Disposed 2025-02-17 Common Stock (5000) Direct
2021-11-11 Stock Options $27.68 M 5000 Disposed 2026-02-04 Common Stock (5000) Direct

Footnotes

F1: Represents a withholding of 6,149 shares of the Issuer's common stock to satisfy the exercise price and the tax obligation in connection with the exercise of certain stock options.

F2: These options vested in three equal annual installments beginning on February 5, 2015.

F3: These options vested in three equal annual installments beginning on February 17, 2016.

F4: These options vested in three equal annual installments beginning on February 4, 2017.